In one meta-analysis, there was no significant associations between XRCC3 Thr241Met and cancer of the bladder, breast, lung or skin [33], but in another meta-analysis the Met/Met genotype showed a small cancer risk with the strongest effect found for breast cancer [34]. This evidence concerns the gene XRCC3 and urinary bladder carcinoma.